Do Firms Get High? The Impact of Medical Marijuana Legalization on Firm Performance and Corporate Innovation
Financial Management · 18.03.2026
DOI: 10.1111/fima.70037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Financial Management, online erschienen am 18.03.2026. Verfasst von Shagun Pant und 2 weiteren Autor:innen. Die Arbeit nennt 61 Literaturangaben.
Abstract (Originalsprache)
We find that state‐level medical marijuana legalization has a positive financial impact on firms, likely by affecting firms’ human capital. Firms headquartered in marijuana‐legalizing states receive higher market valuations, improve employee productivity, and increase innovation. Exploiting inventor mobility data, we directly test the human capital channel and find that states legalizing marijuana are able to retain inventors who become more productive and recruit more innovative talents from out of state.
Zitieren
APA
Pant, S., Wang, J., & Yao, T. (2026). Do Firms Get High? The Impact of Medical Marijuana Legalization on Firm Performance and Corporate Innovation. Financial Management. https://doi.org/10.1111/fima.70037
Vancouver
Pant S, Wang J, Yao T. Do Firms Get High? The Impact of Medical Marijuana Legalization on Firm Performance and Corporate Innovation. Financial Management. 2026. doi:10.1111/fima.70037
BibTeX
@article{Pant2026,
author = {Pant, Shagun and Wang, Jue and Yao, Tong},
title = {Do Firms Get High? The Impact of Medical Marijuana Legalization on Firm Performance and Corporate Innovation},
journal = {Financial Management},
year = {2026},
doi = {10.1111/fima.70037}
}
EUVIMED